Ivím Health

Ivím Health operates as a telehealth-focused medical wellness clinic serving patients throughout Ohio from its Columbus base, established in 2021 under the medical direction of Jessica Duncan, MD. The clinic specializes in GLP-1 receptor agonist therapy for weight management and hormone optimization protocols delivered entirely through virtual consultations. With over 9,000 patient reviews averaging 4.9 stars, Ivím Health has built its practice model around remote access to prescription weight loss medications and ongoing clinical monitoring without requiring in-person office visits.

The clinic's treatment portfolio centers on three FDA-approved GLP-1 medications: semaglutide, tirzepatide, and liraglutide, prescribed based on individual patient metabolic profiles and weight loss objectives. Patients receive compounded formulations when clinically appropriate, with dosage titration managed through regular video consultations with nurse practitioners who adjust protocols based on tolerance and response. The telehealth platform allows providers to monitor side effects common to GLP-1 therapy—including nausea, gastrointestinal changes, and appetite suppression—through structured follow-up schedules that typically begin with bi-weekly check-ins during initial dose escalation phases. Each medication protocol includes specific guidance on injection technique, storage requirements, and recognition of adverse reactions that warrant immediate clinical contact.

Dr. Jessica Duncan oversees clinical protocols and supervises the nurse practitioner team responsible for patient assessments, prescription management, and ongoing care coordination. Initial consultations involve comprehensive review of medical history, current medications, contraindications to GLP-1 therapy, and establishment of realistic weight loss targets based on starting BMI and metabolic health markers. The clinical team evaluates patients for conditions that may affect GLP-1 efficacy or safety, including history of pancreatitis, thyroid disorders, or diabetic retinopathy, before finalizing treatment recommendations. Hormone optimization services address testosterone, thyroid, and other endocrine imbalances that may impact weight management outcomes, with lab work coordinated through local Columbus-area facilities or patient-selected providers.

Patients access care through a digital platform that facilitates video consultations, prescription management, and direct messaging with clinical staff for questions between scheduled appointments. The telehealth model eliminates travel requirements for Ohio residents seeking medical weight loss support, with medications shipped directly to patient addresses following each consultation. Treatment costs, insurance coverage limitations, and self-pay pricing structures are discussed during initial intake, as GLP-1 medications for weight loss frequently fall outside standard insurance formularies. The clinic provides prior authorization support when coverage exists and offers compounded alternatives when brand-name formulations prove cost-prohibitive or unavailable due to national supply constraints affecting semaglutide and tirzepatide availability.

Ivím Health's operational structure reflects the growing demand for remote medical weight loss services in Ohio, where the clinic has processed thousands of patient consultations since opening in 2021. The high volume of reviews mentioning specific medications, dosage adjustments, and telehealth convenience indicates an established patient base utilizing ongoing GLP-1 therapy rather than single consultations. The clinic's focus remains narrow—GLP-1 weight loss protocols and hormone optimization—rather than attempting to serve as a comprehensive primary care provider, which allows for specialized expertise in managing the specific challenges of long-term peptide therapy for metabolic health.